GPCR — Structure Therapeutics Inc. American Depositary Shares price, chart and key statistics

Price data

Price

$20.00

YTD price return

-71.24%

YTD total return

-71.24%

Market cap

1.4B2023-03 910.3M2026-11 1.4B+57.4% over the window

Enterprise value

198.6M

Shares outstanding

71.6M2022-12 3.5M2026-09 71.6M+1940.2% over the window

52W low

$18.70

52W high

$94.90

From 52W high

-78.93%

From 52W low

+6.95%

52W range

2%$18.70–$94.90

Volume

Rel volume

1.21×

30D volume

1.1M

30D $ vol

25M

Fundamentals

EPS (ttm)

-$4.182022-12 -$16.532026-09 -$4.18-74.7% over the window

FCF (ttm)

-277.3M2022-12 -46.3M2026-09 -277.3M+499.2% over the window

FCF/share

-$3.872022-12 -$13.192026-09 -$3.87-70.6% over the window

Book value/share

$17.072022-12 -$32.812026-09 $17.07-152.0% over the window

ROE

-24.05%2023-12 -19.8%2026-09 -24.1%+21.6% over the window

ROA

-22.02%2022-12 -52.5%2026-09 -22.0%-58.0% over the window

Current ratio

11.912022-12 7.162026-09 11.91+66.4% over the window

Growth (CAGR, ttm) · 10Y

Shares

+18.00%2025-09-30 → 2026-09-3060.7M → 71.6M (+18.0% total)+15.56%2023-09-30 → 2026-09-3046.4M → 71.6M (+54.3% total)n/an/a

Per-share growth (CAGR, ttm) · 10Y

Book value/share

+34.52%2025-09-30 → 2026-09-30$12.69 → $17.07 (+34.5% total)+60.07%2023-09-30 → 2026-09-30$4.16 → $17.07 (+310.3% total)n/an/a

Price

-42.88%2025-11-13 → 2026-11-13$35.00 → $20.00 (-42.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-28.47%2023-11-13 → 2026-11-13$54.67 → $20.00 (-63.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/an/a

Total return

-42.88%2025-11-13 → 2026-11-13$35.00 → $20.00 (-42.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-28.47%2023-11-13 → 2026-11-13$54.67 → $20.00 (-63.4% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/an/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-4.8×2024-03 -22.292026-11 -4.87-78.1% over the window

Fwd P/E

-8.0×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

1.2×2023-03 3.852026-11 1.17-69.6% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-19.37%2022-12 -5.1%2026-09 -12.4%+144.4% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-09-30) ÷ shares_at(2025-09-30) = 1 − 71.6M ÷ 60.7M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-18.00%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-18.00%) + dividends paid over that year ($0) ÷ market_cap_at(2025-09-30) ($1.7B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-18.00%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.4B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2023-12 0.0%2026-09 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.4B). Same caveat as the cash buyback yield.

0.00%2023-12 0.0%2026-09 0.0%

Vs own 10Y history

P/B

1st